- Solid oral veterinary excipients, which serve as inactive components used to formulate stable and effective oral dosage forms for animals, are gaining importance across the EMEA region as demand rises for efficient animal healthcare products that ensure palatability, stability, and targeted delivery of active pharmaceutical ingredients
- The growth of the EMEA solid oral veterinary excipients market is primarily driven by an expanding livestock population, increasing pet ownership, heightened awareness of animal health and welfare, and strengthened regulatory focus on the development of safe and standardized veterinary pharmaceutical formulations
- Europe dominated the EMEA solid oral veterinary excipients market with the largest revenue share of 59.2% in 2024, owing to its well-regulated veterinary pharmaceutical landscape, strong R&D infrastructure, and significant presence of leading excipient and animal health companies, particularly in Germany, France, and the U.K.
- The Middle East and Africa are expected to be the fastest-growing region in the EMEA solid oral veterinary excipients market during the forecast period, due to expanding veterinary infrastructure, increasing government initiatives for animal disease control, and the growing commercial livestock sector
- The binders segment dominated the EMEA solid oral veterinary excipients market with a market share at 37.5% in 2024, attributed to their critical role in maintaining tablet integrity, improving mechanical strength, and enabling uniform distribution of active ingredients across a range of veterinary formulations
